AkzoNobel Q4 operating income rises to EUR 787 million, up more than sixfold

Reuters
02/03
AkzoNobel Q4 operating income rises to EUR 787 million, up more than sixfold

AkzoNobel reported its fourth quarter (Q4) 2025 earnings, with revenue down 9% to EUR 2.38 billion, driven by lower volumes and negative foreign exchange translation effects. Organic sales declined 1% during the period. Operating income for Q4 2025 increased to EUR 787 million, supported by the completion of the divestment of Akzo Nobel India Ltd, which contributed proceeds of EUR 922 million and an operating income impact of EUR 655 million. Adjusted EBITDA reached EUR 309 million for the quarter, with the adjusted EBITDA margin expanding to 13.0%, up from 12.3% in the previous year, reflecting ongoing efficiency actions. Net cash from operating activities was positive at EUR 462 million in Q4 2025. Key corporate developments include the closing of the sale of Akzo Nobel India Ltd at a valuation of 25 times EBITDA, and a proposed merger with Axalta to create a premier global coatings company. The company also reported a reduction in workforce to 31,500 employees at December 31, 2025, following efficiency programs and the India divestment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akzo Nobel NV published the original content used to generate this news brief on February 03, 2026, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10